4688
M. Sugawara, J. Yoshida / Tetrahedron 56 (2000) 4683±4689
87%). TLC Rf 0.31 (hexane/EtOAc10/1); 1H NMR
(CDCl3) d 0.09 (dd, J10.2, 4.5 Hz, 2H), 0.54 (ddd,
J10.5, 5.7, 4.5 Hz, 2H), 0.90±1.00 (m, 1H), 2.27 (d,
J7.2 Hz, 2H), 2.70±2.84 (m, 2H), 2.85±2.95 (m, 2H),
7.10±7.40 (m, 5H); 13C NMR (CDCl3) d 4.33, 6.15,
29.57, 43.78, 48.20, 126.11, 128.39, 128.53, 141.28,
210.28; IR (neat) 3090 (cyclopropane C±H), 1716 (CvH)
cm21; MS (EI) m/e (%) 188 (M1, 60), 159 (30), 133 (85);
HRMS (EI) calcd for C13H16O 188.1201, found 188.1204;
Anal. Calcd for C13H16O: C, 82.94; H, 8.57. Found: C,
82.74; H, 8.53.
erythro-2-Cyclopropyl-1-cyclohexylpropan-1-ol (erythro-
3g). TLC Rf 0.25 (hexane/EtOAc10/1); 1H NMR
(CDCl3) d 0.06±0.12 (m, 2H), 0.40±0.52 (m, 2H), 0.68±
0.77 (m, 1H), 0.81±0.91 (m, 1H), 0.94 (d, J6.3 Hz, 3H),
0.95±1.05 (m, 2H), 1.10±1.35 (m, 3H), 1.40±1.58 (m, 3H),
1.60±1.80 (m, 3H), 1.98 (d, J12.6 Hz, 1H), 3.30 (dd,
J7.8, 3.6 Hz, 1H); 13C NMR (CDCl3) d 3.76, 3.87,
12.74, 15.42, 25.88, 26.14, 26.40, 29.00, 29.41, 40.19,
40.29, 79.92; IR (neat) 3360 (br, OH), 3075 (cyclopropane
C±H) cm21; MS (EI) m/e (%) 153 (M12C2H5, 2), 135 (10),
113 (42); HRMS (EI) calcd for C12H22O±C2H5 153.1279,
found 153.1277; Anal. Calcd for C12H22O: C, 79.06; H,
12.16. Found: C, 79.23; H, 11.91.
1-Cyclopropyl-4-phenylbutan-2-ol (3c). TLC Rf 0.11
1
(hexane/EtOAc10/1), H NMR (CDCl3) d 0.00±0.20 (m,
2H), 0.40±0.60 (m, 2H), 0.68±0.81 (m, 1H), 1.35±1.45 (m,
2H), 1.71±1.85 (m, 2H), 2.68 (ddd, J13.8, 9.9, 6.9 Hz,
1H), 2.80 (ddd, J13.8, 9.6, 6.9 Hz, 1H), 3.70±3.80 (m,
1H), 7.15±7.40 (m, 5H); 13C NMR (CDCl3) d 3.54, 4.36,
7.21, 31.97, 38.68, 42.23, 71.85, 125.82, 128.44, 128.50,
142.34; IR (neat) 3350 (br, OH), 3090 (cyclopropane
C±H) cm21; MS (EI) m/e (%) 190 (M1, 12), 172 (65),
143 (30); HRMS (EI) calcd for C13H18O±H2O 172.1252,
found 172.1243.; Anal. Calcd for C13H18O: C, 82.06; H,
9.53. Found: C, 81.82; H, 9.66.
threo-2-Cyclopropyl-1-cyclohexylpropan-1-ol (threo-3g).
1
TLC Rf 0.27 (hexane/EtOAc10/1); H NMR (CDCl3) d
0.04 (dt, J9.3, 5.4 Hz, 1H), 0.29 (dt, J5.4, 3.6 Hz, 1H),
0.38±0.50 (m, 1H), 0.50±0.65 (m, 2H), 0.82±0.95 (m, 1H),
0.96 (d, J0.9 Hz, 3H), 1.00±1.40 (m, 6H), 1.45±1.80
(m, 6H), 3.20±3.30 (m, 1H); 13C NMR (CDCl3) d 1.29,
4.96, 13.97, 16.93, 26.11, 26.20, 26.52 (probably a
signal of another carbon is buried), 30.50, 40.06, 40.26,
81.36; MS (EI) m/e (%) 182 (M1, 1), 164 (3), 153 (10);
HRMS (EI) calcd for C12H22O±C2H5 153.1279, found
153.1284.
1-(1-Methylcyclopropyl)-4-phenylbutan-2-ol (3d). TLC
1
Rf 0.17 (hexane/EtOAc10/1), H NMR (CDCl3) d 0.20±
1-Phenylhept-6-en-3-one (4b). TLC Rf 0.33 (hexane/
1
0.38 (m, 3H), 0.39±0.45 (m, 1H), 1.06 (s, 3H), 1.22 (dd,
J13.8, 9.0 Hz, 1H), 1.63 (ddd, J14.1, 3.9, 1.2 Hz, 1H),
1.70±1.90 (m, 2H), 2.69 (ddd, J13.8, 9.6, 6.6 Hz, 1H),
2.81 (ddd, J13.8, 9.6, 6.6 Hz, 1H), 3.85±3.93 (m, 1H),
7.20±7.35 (m, 5H); 13C NMR (CDCl3) d 11.93, 12.62,
12.84, 22.65, 31.96, 39.17, 46.53, 69.80, 125.81, 128.44,
128.50, 142.39; IR (neat) 3370 (br, OH), 3067 (cyclo-
propane C±H) cm21; MS (EI) m/e (%) 204 (M1, 2), 186
(38), 157 (25); HRMS (EI) calcd for C14H20O±H2O
186.1408, found 186.1404.
EtOAc10/1); H NMR (CDCl3) d 2.31 (dt, J6.6 and
6.9 Hz, 2H), 2.49 (t, J6.9 Hz, 2H), 2.74 (t, J7.2 Hz,
2H), 2.91 (t, J7.2 Hz, 2H), 4.98 (dt, J10.2, 1.8 Hz,
1H), 5.01 (dq, J16.8, 1.8 Hz, 1H), 5.84 (ddd, J16.8,
10.2, 6.6 Hz, 1H), 7.15±7.40 (m, 5H); 13C NMR (CDCl3)
d 27.61, 29.62, 41.95, 44.30, 115.32, 126.17, 128.39,
128.57, 137.13, 141.17, 209.47; IR (neat) 2926, 1717
(CvH), 1455 cm21; MS (EI) m/e (%) 188 (M1, 30), 133
(65), 105 (100); HRMS (EI) calcd for C13H16O 188.1201,
found 188.1205. Anal. Calcd for C13H16O: C, 82.94; H,
8.57. Found: C, 82.74; H, 8.53.
erythro-4-Cyclopropyl-1-phenylpentan-3-ol (3e). TLC Rf
0.17 (hexane/EtOAc10/1), 1H NMR (CDCl3) d 0.02±0.10
(m, 1H), 0.12±0.22 (m, 1H), 0.45 (dd, J8.7, 2.1 Hz, 2H),
0.58±0.70 (m, 1H), 0.72±0.84 (m, 1H), 0.97 (d, J6.6 Hz,
3H), 1.70±1.95 (m, 2H), 2.65 (ddd, J13.8, 9.9, 6.6 Hz,
1H), 2.86 (ddd, J13.8, 9.9, 6.6 Hz, 1H), 3.62 (dt, J9.0,
3.9 Hz, 1H), 7.15±7.30 (m, 5H); 13C NMR (CDCl3) d 3.01,
4.31, 14.04, 14.47, 32.58, 36.33, 44.03, 75.48, 125.82,
128.44, 128.50, 142.45; IR (neat) 3370 (br, OH), 3085
(cyclopropane C±H) cm21; Anal. Calcd for C14H20O: C,
82.30; H, 9.87. Found: C, 82.16; H, 9.75.
1-Phenylhept-6-en-3-ol (4c). TLC Rf 0.11 (hexane/
EtOAc10/1), 1H NMR (CDCl3) d 1.42 (d, J5.1 Hz,
1H), 1.54±1.64 (m, 2H), 1.70±1.82 (m, 2H), 2.05±2.24
(m, 2H), 2.68 (ddd, J13.8, 9.3, 6.9 Hz, 1H), 2.81 (ddd,
J13.8, 9.3, 6.9 Hz, 1H), 3.62±3.72 (m, 1H), 4.96 (dt,
J10.2, 1.8 Hz, 1H), 5.04 (dq, J17.7, 1.8 Hz, 1H), 5.84
(ddd, J17.7, 10.2, 6.9 Hz, 1H), 7.15±7.40 (m, 5H); 13C
NMR (CDCl3) d 29.97, 31.96, 36.51, 39.12, 70.94,
114.92, 125.90, 128.50 (2 carbons), 138.59, 142.21; IR
(neat) 3400 (OH), 1641, 1454 cm21; MS (EI) m/e (%) 190
(M1, 3), 172 (40), 130 (65); HRMS (EI) calcd for C13H18O±
H2O 172.1252, found 172.1251.
erythro-2-Cyclopropyldecan-3-ol (3f). TLC Rf 0.25
(hexane/EtOAc10/1); 1H NMR (CDCl3) d 0.02±0.10
(m, 1H), 0.14±0.20 (m, 1H), 0.47 (dd, J8.4, 2.1 Hz, 2H),
0.60±0.80 (m, 2H), 0.87 (t, J8.4 Hz, 3H), 0.97 (d,
J6.6 Hz, 3H), 1.20±1.60 (m, 12H), 3.55±3.65 (m, 1H);
13C NMR (CDCl3) d 3.10, 4.21, 13.77, 13.97, 14.63,
22.54, 26.17, 29.22, 29.60, 31.76, 34.60, 43.84, 75.97; IR
(neat) 3360 (br, OH), 3075 (cyclopropane C±H) cm21; MS
(EI) m/e (%) 180 (M12H2O, 2), 169 (10), 151 (2); HRMS
(EI) calcd for C13H26O±C2H5 169.1592, found 169.1591;
Anal. Calcd for C13H26O: C, 78.72; H, 13.21. Found: C,
78.51; H, 12.95.
Molecular orbital calculations
The ab initio calculations were carried out using the
gaussian 98 program16 at the MP2/LANL2DZ level.
All geometries were fully optimized and all the
optimized structures were local minima according to the
vibration frequency analyses. Relative energies were
corrected for ZPE (zero point energy) calculated at MP2/
LANL2DZ.